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INTRODUCTION
While sequencing of the human 
genome has obviously been a major 
benefit to genomics, it has also opened 
a number of research opportunities 
in proteomics: thousands of open 
reading frames (ORFs) can now be 
cloned and expressed as proteins (1). 
Significant efforts have been devoted 
to converting these clones into 
soluble, purified proteins that can be 
used for structural studies (2,3). There 
are presently a number of structural 
proteomics initiatives around the 
world that use X-ray crystallography 
or nuclear magnetic resonance (NMR) 
spectroscopy attempting to determine 
the three-dimensional (3-D) struc-
tures of one or more proteins from 
each protein family with the goal of 
predicting their function (4,5). While 
computational methods of predicting 
a protein’s 3-D structure based on its 
sequence have dramatically improved 
(6,7), a large number of proteins 
remain whose sequences do not 
show enough homology to known 
structures to make structure predic-
tions successful (8). In these cases, 
sufficient amounts of the protein 
must be expressed and purified prior 
to acquisition of the requisite X-ray 
crystallography or NMR spectroscopy 
data. Arguably the rate-limiting step in 
structural biology is in the production 
of large amounts of proteins with high 
enough quality for structural studies. 
Current figures estimate that roughly 
half of the proteins represented within 
the human genome are expected to 
be difficult to express or solubilize 
(9–11).
Another area in which purified 
proteins arising from the predicted 
ORFs in the human genome would 
have a tremendous impact is in the 
generation of affinity reagents (12,13). 
Array platforms for genomic analysis 
are commonplace; however, their use 
in proteomics has not been able to keep 
pace due to the lack of high affinity 
reagents for large numbers of proteins 
found in the human proteome. While 
antibodies can be generated against 
synthetic peptides, the availability of 
the native protein generally produces 
reagents with greater specificity and 
utility.
One of the bottlenecks in acquiring 
a sufficient amount of purified protein 
with which to conduct structural 
studies or generate affinity reagents 
is obtaining high levels of soluble 
expression (9). Determining the 
expression characteristics of a cloned 
ORF in a specific system and under a 
specific set of conditions is usually a 
matter of trial and error (14,15). The 
standard approach requires cloning 
individual ORFs into an expression 
vector, which is introduced into an 
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expression host, and then expressed 
in separate cultures under a number of 
different conditions such as induction, 
time, and temperature. Those cultures 
that show positive expression are 
grown and induced at a scaled-up 
level so that protein purification can 
be attempted. While automation has 
helped, the logistics and costs of 
this high-risk strategy are enormous 
when one considers the expression of 
hundreds or thousands of ORFs.
We previously described a method 
termed pooled ORF expression 
technology (POET) that combines 
recombinational cloning and collec-
tions of sequenced ORFs with 
proteomic methods [two-dimensional 
polyacrylamide gel electropho-
resis (2D-PAGE) and tandem mass 
spectrometry (MS/MS)] to predict 
which ORFs in a pool will yield 
soluble, purified protein (16). While 
this method had a high success rate in 
identifying which ORFs expressed high 
levels of soluble protein, its overall 
throughput was low. The bottleneck in 
the procedure was the need to separate 
the protein mixture using 2D-PAGE 
prior to MS/MS identification of the 
hundreds of visualized proteins spots. 
In addition, Escherichia coli proteins 
cannot be distinguished from those 
expressed by the human ORFs using 
2D-PAGE, resulting in a necessarily 
high percentage of the experimental 
time being devoted to identification 
of host proteins. As described below, 
we have dramatically improved the 
throughput of POET by obviating the 
need to quantify the expressed proteins 
through visualization of a 2D-PAGE 
gel. In this improved approach, the 
relative abundance of the expressed 
proteins is determined by calculating 
their exponentially modified protein 
abundance index (emPAI) (17) using 
data acquired by direct reversed-phase 
high-performance liquid chromatog-
raphy-MS/MS (LC-MS/MS) analysis 
of the expressed protein pool. As with 
the previous study, a high percentage 
of ORFs identified in this experiment 
yielded expressed, soluble, purified 
proteins in agreement with POET 
predictions. The consistency of the 
data in the nine replicates and the 
simplicity of the method represent 
a significant improvement over the 
earlier POET protocol.
MATERIALS AND METHODS
ORF Pool
The Homo sapiens ORFeome 
version 1 has been described previ-
ously (18). The DNA concentrations 
of the 7864 Gateway entry clones used 
in this experiment were determined 
by PicoGreen (Molecular Probes, 
Invitrogen, Carlsbad, CA, USA) 
fluorescence and used to calculate the 
molar concentration of each plasmid 
(based on the size of each ORF and 
the size of the pDONR223 backbone), 
which ranged from 0 to 23.1 nM. All 
wells containing <0.15 nM plasmid 
concentration were omitted, leaving 
7352 ORFs. These clones were 
further subdivided into two classes 
(“known” and “unknown”) based on 
the following criteria: “unknowns” 
must (i) have no predicted transmem-
brane domains, (ii) have no predicted 
secretion signal sequence, and (iii) 
have no structure of themselves or any 
homolog in the Protein Data Bank. 
We decided on 30% as the cutoff 
for homology to produce a pool of 
proteins of interest to researchers 
that were reasonable likely to be 
purifiable. This “unknown” pool 
contained 3279 clones. The pool was 
subdivided further into six subpools of 
approximately 512 ORFs each, which 
were set up to contain an even distri-
bution of insert sizes. These pools 
were designated U1 through U6, and 
were concentration-normalized by 
the method previously described for 
the POET analysis of ORFs obtained 
from Caenorhabditis elegans (16). 
The pools were ethanol-precipitated 
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Figure 1. Improved pooled open reading frame (ORF) expression technology (POET) method. The green boxes highlight improcxvements made to the 
previous method that dramatically increase the throughput in recognizing clones that efficiently express using POET.
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and dissolved in Tris-EDTA to a final 
concentration of 5 ng/μL.
Protein Expression
A single pool containing 512 
ORFs [as Gateway attL entry clones 
(6)] was subcloned into pDest527 
(T7 promoter, amino-terminal His6
fusion) with LR Clonase (Invitrogen) 
according to the manufacturer’s 
instructions, except that the reaction 
was allowed to proceed for 5 h at 
30°C. Each of the 512 ORFs expressed 
in this vector contained the sequence 
MRSGSHHHHHHRSDITSLYKKAG 
added to its amino end and 
YPAFLYKVVISLAR added to its 
carboxyl end due to the lack of the 
native stop codon. Reaction products 
were transformed into DH5α cells 
(Invitrogen), and 1% of the SOC 
expression mixture was plated on 
ampicillin. The remaining 99% of the 
expression mixture was added to 50 
mL CircleGrow (QBiogene, Carlsbad, 
CA, USA) containing ampicillin, 
and after overnight growth at 37°C, 
plasmid DNA was purified (Fast 
Plasmid; Brinkmann, Westbury, NY, 
USA). Approximately 100 ng pooled 
expression plasmids were electropo-
rated into E. coli Rosetta (DE3) strain 
(Novagen, EMD Chemicals, San 
Diego, CA, USA), which compen-
sates for eukaryotic codons that 
are rare in E. coli. The 1 mL SOC 
expression mixture was diluted 
into 50 mL CircleGrow (containing 
100 μg/mL ampicillin) and grown 
overnight at 37°C. The overnight 
culture was diluted 1:100 into 1 L 
CircleGrow (containing 100 μg/mL 
ampicillin), grown at 37°C to an A600
of 0.5, and cooled to 16°C, at which 
time protein expression was induced 
by adding isopropyl 1-thio-β-D-
galactopyranoside to a final concen-
tration of 0.5 mM. After 16 h at 16°C, 
cells were harvested and frozen at 
-80°C. For individual expression 
of positive and negative clones, 
individual ORFs were subcloned by 
LR recombination into pDest527, and 
expression clones were individually 
transformed into E. coli Rosetta 
(DE3) cells and induced under the 
same conditions as above. Whole-cell 
samples for gel electrophoresis were 
generated by centrifugation of 0.05 
optical density (OD) units of induced 
cells, followed by freeze-thaw at 
-80°C, treatment with 1 U benzonase 
nuclease at 37°C for 15 min, and 
addition of standard sodium dodecyl 
sulfate PAGE (SDS-PAGE) buffers 
and tris(2-carboxyethyl)phosphine 
(TCEP). Soluble fractions were 
generated by a mild detergent lysis 
of 1 OD units of induced cells using 
the Readypreps procedure (Epicentre 
Biotechnologies, Madison, WI, USA). 
All gel samples were analyzed by 
SDS-PAGE using 4%–20% Criterion 
gels (Bio-Rad Laboratories, Hercules, 
CA, USA).
Protein Purification
Proteins were purified using 
immobilized metal affinity chroma-
Table 1. Proteins from Sample 1 (Run in Triplicate), with the Highest emPAI Scores Showing Individual Sample emPAI Score 
  Protein Theoretical Peptide Count
Peptide 
Count
emPAI 
Scores
1a 1b 1c 1a 1b 1c
FKBP-type peptidyl-prolyl cis-trans isomerase slyD 21 5 5 5 0.73020 0.73020 0.73020
Chaperone protein DnaK 177 36 31 36 0.59731 0.49672 0.59731
Protein CGI-38 70 12 12 15 0.48398 0.48398 0.63789
UPF0235 protein C15orf40 36 7 5 5 0.56475 0.37686 0.37686
60 kDa Chaperonin (GroEL) 146 21 22 22 0.39263 0.41477 0.41477
Ferric uptake regulation protein 39 4 6 5 0.26638 0.42510 0.34340
Programmed cell death protein 5 45 5 7 5 0.29155 0.43072 0.29155
Ribosomal small subunit pseudouridine synthase A 54 6 6 5 0.29155 0.29155 0.23764
Developmental pluripotency associated 4 90 8 10 10 0.22713 0.29155 0.29155
26S Proteasome subunit p27 57 5 5 6 0.22383 0.22383 0.27428
Catabolite gene activator 61 6 4 7 0.25418 0.16298 0.30243
Major outer membrane lipoprotein precursor (OmpF) 22 2 2 2 0.23285 0.23285 0.23285
Hypothetical protein MGC43122 37 3 4 3 0.20526 0.28265 0.20526
HCV NS5A-transactivated protein 9 39 3 3 4 0.19378 0.19378 0.26638
KIAA1536 protein 190 16 14 18 0.21398 0.18491 0.24377
Proteins representing cloned human open reading frames (ORFs) are shown in bold. emPAI, exponentially modi ed protein abundance index.
Hey! Scarab’s Clean 
Genome® removed 15% 
from the E. coli K-12 genome—
? Less non-essential genes
? Less pathogenicity related genes
?  Less phage, IS, and transposable genes
? Better clone stability
? Better metabolic efficiency
? Better transfection efficiency
? Better success with problem genes
www.scarabgenomics.com
888-513-7075
tography (IMAC) as described previ-
ously (16). E. coli cell pastes were 
resuspended using two volumes of 
extraction buffer per gram of wet 
weight to achieve a final concentration 
of 20 mM sodium phosphate buffer, 
pH 7.5, 100 mM NaCl, 5 mM MgCl2, 
5% glycerol, 45 mM imidazole, and 
complete protease inhibitor-EDTA 
(Roche Applied Science, Indianapolis, 
IN, USA) at one tablet/50 mL extract. 
Cell extracts were treated with 0.5 mg/
mL lysozyme for 30 min and 1 U/mL 
benzonase (Novagen) for an additional 
20 min. Samples were sonicated to lyse 
the cells, and the lysates was adjusted 
to 500 mM NaCl. The lysate was 
centrifuged at 111,000× g for 30 min, 
filtered (0.45 μm, polyethersulfone 
membrane), and applied at 0.6 mL/min 
to 1 ml HisTrap columns (Amersham 
Biosciences, Piscataway, NJ, USA) 
equilibrated with extraction buffer in 
500 mM NaCl and 45 mM imidazole 
(binding buffer). The columns were 
washed with binding buffer until the 
levels of protein flowing through the 
column reached base line. Bound 
proteins were eluted with binding 
buffer containing 500 mM imidazole 
into 1 mL fractions, which were subse-
quently analyzed using SDS-PAGE. 
The pools created from the IMAC 
fractions were precipitated by adding 
25% (v/v) trichloroacetic acid (TCA) 
to a final concentration of 6% (v/v). 
After vortex mixing, the samples were 
incubated on ice for 5 min followed 
by centrifugation at 16,100× g for 10 
min. The supernatant was removed, 
and the pellet incubated with ice-cold 
acetone for 5 min on ice followed 
by centrifugation at 16,100× g for 5 
min. The supernatant was discarded, 
and the pellet was dried for 2 min at 
70°C. The pellet was finally dissolved 
in solubilization buffer (8 M urea, 4%
CHAPS, 50 mM Tris, pH 8.5) at room 
temperature to a concentration of 20 
mg/mL and stored in 50 μL aliquots 
at -80°C.
Sample Preparation and MS/MS 
Analysis
The pooled samples were digested 
with trypsin using 5 mM dithiothreitol 
(DTT), 25 mM NH4HCO3, and 0.5 μg 
Figure 2. SDS-PAGE analysis of 11 pooled open reading frame (ORF) expression technology 
(POET) positives [high exponential modified protein abundance (emPAI) scores, lanes 1–11] and 
negatives (emPAI scores equal to zero, lanes 12–22) from whole-cell extracts and soluble superna-
tants of induced small-scale cultures containing individual clones. The yellow dots indicate the posi-
tions of the stained protein band produced from expression of the individual cloned ORF. The numbering 
of the gel lanes correspond to the ORFs listed in Tables 4 and 5.
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To illustrate the performance of the system, we focused on single nucle-
study (see Table 1) (i.e., 22 oligonucleotides). Their length varied from 19 to 24 bases, and they were synthesized without any modification. Control oligonucleotides consisted of 50-mers 
tions were the same as those of the first amplification round, and the program consisted of a standard touchdown reaction composed of 20 cycles, with an annealing temperature decreasing from 60? to 50?C, followed by 25 cycles with 
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designed from the mouse labeled with a Cy5 dye at their 3extremity and harboring a C6-NH2  extremity (see Table 1). All the oligonucleotides were synthesized by Operon Biotechnologies GmbH (Cologne, Germany).
Microarray Preparation
The slides used in this study were reflective slides (AmpliSlides; Genewave, Palaiseau, France) designed for optimal photon collection, providing a signal-to-noise enhancement by a factor of 4 to 5 (16). These slides are coated with an epoxysilane layer for covalent attachment. Probes were resuspended in a spotting buffer (Genewave) M and spotted with a split m diameter) under 60humidity with a MicroGrid II spotter (BioRobotics, Cambridge, UK). For control purposes, probes were spotted in triplicate on four identical blocks in the center of the microarray (see Figure 1B). Positive controls were also spotted in five replicates on each block. Slides were then mounted in cartridges as described in the Fluidics section.
For LHM validation, we used oligonucleotide-oligonucleotide hybridizations. The targets consisted of the 11 reverse complement sequences of the so-called perfect matched (PM) oligonucleotides of each probe pair (Table 1)
 terminus. For hybridization of PCR products, each locus was first amplified as described in Bailly et al. (15), then purified with the QIAquick PCR Purification kit (Qiagen, Valencia, CA, USA) and quantified with the NanoDrop 1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). For labeling purposes, a second amplification was carried out 
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on 5 ng each product, using one oligo-nucleotide probe as the forward primer and one Cy5-labeled oligonucleotide target as the reverse primer. PCR condi-
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INTRODUCTION
DNA microarray technology, with its ability to simultaneously detect and measure thousands of distinct DNA sequences immobilized on a small surface area, has been widely recognized as a valuable tool for high-throughput, quantitative, systematic, and detailed studies for a wide panel of applications (1,2). So far, this technology relies on end point measurement of hybridization events. This is a serious limitation in terms of both performance and cost. The ability to monitor these hybrid-ization events simultaneously in real time and under adjustable temperature would lead to two major improve-ments. First, it would give access to the measurement of the thermody-namic and kinetic parameters [e.g., the melting temperature (Tm)] that control 
the hybridization of surface-bound probes. It is indeed commonly reported that there is no reliable predictor of on-chip hybridization efficiency, because solution-based hybridization predic-tions are not relevant for solid-phase hybridizations (3,4). Therefore, design and optimization of DNA microarrays remain a chief obstacle, and their reliability with regard to sensitivity and specificity constitutes a major challenge for users to transform them into robust tools (5). Second, real-time monitoring of hybridization would enable a quick and cost-effective optimization of experimental conditions by offering the possibility to test several hybridization temperatures and buffer compositions within a single experiment.Although other groups have reported real-time hybridization and thermal denaturation measurements (6–14), a 
complete stand-alone system compatible with standard microarray slides is still lacking. We have addressed this problem by developing an innovative biochip tool that integrates a real-time fluorescence reader to a hybridization/washing station equipped with highly efficient mixing and precise temperature controls. This integrated live hybrid-ization machine (LHM), which will soon be commercially available, allows real-time measurement of the hybrid-ization and melting of target DNA to thousands of probes simultaneously.Here we describe the performance of the LHM with a set of oligonucle-otide probes aimed at discriminating polymorphisms in the symbiotic sister species Sinorhizobium meliloti and Sinorhizobium medicae. Our results show that the LHM provides excellent levels of detection and superior 
Innovative integrated system for real-time measurement of hybridization and melting on standard format microarrays
Yann Marcy1, Pierre-Yves Cousin1, Maxime Rattier1, Gordana Cerovic1, Guilhem Escalier1, 
Gilles Béna2, Maurice Guéron1, Lorcan McDonagh1, Françoise le Boulaire1, Henri Bénisty3, 
Claude Weisbuch4, and Jean-Christophe Avarre1
BioTechniques 44:913-920 (June 2008)doi 10.2144/000112758
Despite the great popularity and potential of microarrays, their use for research and clinical applications is still ha pered by 
lengthy and costly design and optimization processes, mainly because the technology relies on the end point measurement of hy-
bridization. Thus, the ability to monitor many hybridization events on a standard microarray slide in real time would greatly expand 
the use and benefit of this technology, as it would give access to better prediction of probe performance and improved optimiza-
tion of hybridization parameters. Although real-time hybridization and thermal denaturation measurements have been reported, a 
complete walk-away system compatible with the standard format of microarrays is still unavailable. To address this issue, we have 
designed a biochip tool that combines a hybridization station with active mixing capability and temperature control together with a 
fluorescence reader in a single compact benchtop instrument. This integrated live hybridization machine (LHM) allows measuring 
in real time the hybridization of target DNA to thousands of probes simultaneously and provides excellent levels of detection and 
superior sequence discrimination. Here we show on an environmental single nucleotide polymorphism (SNP) model system that the
LHM enables a variety of experiments unachievable with conventional biochip tools.
1Genewave, Ecole Polytechnique Campus, Palaiseau, 2Laboratoire des Symbioses Tropicale et Méditerranéenn s, 
Campus International de Baillarguet, Montpellier, 3Institut d’Optique Graduate School, Ecole Polytechnique Campus, 
Palaiseau, and 4Laboratoire de Physique de la Matière Condensée, Centre National de la Recherche Scientifique (CNRS)-
Ecole Polytechnique, Palaiseau Cedex, France
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sequencing-grade modified trypsin 
(Promega, Madison, WI, USA). All of 
the samples were desalted with C18 Zip 
Tips (Millipore, Billerica, MA, USA) 
following the manufacturer’s protocols 
prior to MS analysis. Chromatographic 
separations of desalted tryptic peptides 
were conducted using nanocolumns 
prepared in-house. A 75 μm inner 
diameter × 360 μm outer diameter 
× 10 cm–long fused silica capillary 
column (Polymicro Technologies, 
Phoenix, AZ, USA) with one end 
flame-pulled to a fine tip (∼5- to 7-μm 
orifice) was slurry-packed with 5 μm, 
300-Å pore size C18 stationary phase 
(Phenomenex, Torrance, CA, USA).
The reversed-phase separations 
were performed by injecting 5 μL 
sample per analysis. The columns were 
connected via a stainless steel union to 
an Agilent 1100 Nanoflow LC system 
(Agilent Technologies, Palo Alto, 
CA, USA), which was used to deliver 
solvents A (0.1% HCOOH in water) 
and B (0.1% HCOOH in CH3CN). 
After the sample was injected, a 20 
min wash with 98% mobile phase A 
was used to flush any remaining salts 
from the sample. Peptide elution was 
accomplished using a linear gradient 
of 2% mobile phase B to 42% solvent 
B over 40 min with a constant flow 
rate of 250 nL/min. The column was 
flushed for 15 min with 98% mobile 
phase B and re-equilibrated with 98%
mobile phase A prior to subsequent 
sample loading.
The nanoflow reversed-phase 
LC column was coupled online to 
a LIT mass spectrometer (LTQ; 
ThermoElectron, Thermo Fisher 
Scientitic, San Jose, CA, USA) using 
the manufacturer’s nanoelectrospray 
source with an applied electrospray 
potential of 1.7 kV and capillary 
temperature of 160°C. The LIT mass 
spectrometer was operated in a data-
dependent mode in which each full 
MS scan was followed by five MS/MS 
scans, where the five most abundant 
peptide molecular ions detected from 
the MS scan were dynamically selected 
for five subsequent MS/MS scans 
using a normalized collision-induced 
dissociation (CID) energy of 35% and 
a dynamic exclusion of 60 s to reduce 
redundant selection of peptides. The 
CID spectra were analyzed using 
SEQUEST operating on a Beowulf 
18-node parallel virtual machine 
cluster computer (ThermoElectron, 
Thermo Fisher Scientific, Waltham, 
MA, USA) using a combined UniProt 
nonredundant E. coli and human 
proteome database (containing 43,137 
protein sequences) downloaded 
January 2006 (www.expasy.org). 
Only peptides with conventional 
tryptic termini (allowing for up to two 
internal missed cleavages) possessing 
delta-correlation scores (ΔCn) > 0.08 
and charge state-dependent cross-
correlation (Xcorr) criteria as follows 
were considered as legitimate identifi-
Table 2. Mean emPAI Scores Obtained from Three Separate POET Experiments
  Protein emPAI Scores 
Exp 1 Exp 2 Exp 3
FKBP-type peptidyl-prolyl cis-trans isomerase slyD 0.730 ± 0.000 0.804 ± 0.220 0.670 ± 0.104
Chaperone protein DnaK 0.564 ± 0.581 0.459 ± 0.057 0.415 ± 0.039
Protein CGI-38 0.535 ± 0.089 0.363 ± 0.126 0.469 ± 0.056
UPF0235 protein C15orf40 0.440 ± 0.108 0.500 ± 0.056 0.670 ± 0.107
60 kDa Chaperonin (GroEL) 0.407 ± 0.013 0.386 ± 0.067 0.349 ± 0.000
Ferric uptake regulation protein 0.345 ± 0.079 0.427 ± 0.084 0.151 ± 0.105
Programmed cell death protein 5 0.338 ± 0.080 0.435 ± 0.130 0.535 ± 0.121
Ribosomal small subunit pseudouridine synthase A 0.274 ± 0.031 0.295 ± 0.110 0.238 ± 0.000
Developmental pluripotency associated 4 0.271 ± 0.037 0.292 ± 0.057 0.239 ± 0.080
26S Proteasome subunit p27 0.241 ± 0.029 0.241 ± 0.029 0.208 ± 0.057
Catabolite gene activator 0.240 ± 0.071 0.338 ± 0.106 0.164 ± 0.044
Major outer membrane lipoprotein precursor (OmpF) 0.233 ± 0.000 0.151 ± 0.071 0.237 ± 0.129
Hypothetical protein MGC43122 0.231 ± 0.045 0.183 ± 0.087 0.110 ± 0.039
HCV NS5A-transactivated protein 9 0.218 ± 0.042 0.218 ± 0.042 0.082 ± 0.037
KIAA1536 protein 0.214 ± 0.029 0.214 ± 0.015 0.235 ± 0.056
Optineurin 0.210 ± 0.053 0.214 ± 0.015 0.159 ± 0.041
Hypothetical protein MGC4504 0.199 ± 0.000 0.152 ± 0.041 0.176 ± 0.041
Coiled-coil domain-containing protein 16 0.197 ± 0.013 0.182 ± 0.022 0.125 ± 0.024
RNA-binding protein with multiple splicing 0.180 ± 0.065 0.076 ± 0.034 0.057 ± 0.058
Drebrin-like protein 0.178 ± 0.014 0.257 ± 0.083 0.161 ± 0.043
30S Ribosomal subunit protein S15 0.157 ± 0.083 0.075 ± 0.000 0.075 ± 0.000
Bifunctional polymyxin resistance arnA protein 0.136 ± 0.010 0.114 ± 0.010 0.077 ± 0.032
Hypothetical protein MGC20255 0.133 ± 0.035 0.144 ± 0.021 0.064 ± 0.000
KIAA1143 0.129 ± 0.000 0.129 ± 0.046 0.056 ± 0.025
Sperm surface protein Sp17 0.124 ± 0.033 0.034 ± 0.030 0.017 ± 0.030
emPAI, exponentially modi ed protein abundance index; POET, pooled open reading frame (ORF) expression technology.
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cations: >1.9 for +1 charged peptides, 
>2.2 for +2 charged peptides, and >3.1 
for +3 charged peptides.
Quantitation of Protein Abundance
The relative abundance of proteins 
in the POET pooled was calculated 
using emPAI as described previously 
(17). In this method, the PAI value 
for each protein is initially calculated 
and then converted to a corresponding 
emPAI score by raising 10 to the 
power of PAI, then subtracting 1 
(10PAI–1). The PAI value is determined 
by dividing the number of experi-
mentally identified peptide fragments 
from an MS analysis by the total 
number of possible observable peptide 
fragments (Nobsvd/Nobsvbl) for each 
individual protein. The emPAI index 
allows a quick and easy estimation of 
total protein content by normalizing 
the data to the number of theoretical 
peptides in a mixture of proteins. The 
emPAI values were calculated and 
averaged over three separate LC-MS/
MS analyses of each of the three 
samples of purified proteins obtained 
from the expressed ORF pools (nine 
replicates total).
RESULTS
We previously developed the POET 
method as a procedure for finding 
which ORFs in a pool of hundreds 
of ORFs can be most efficiently 
converted, by cloning, expression, and 
purification, into their corresponding 
recombinant proteins (16). By 
combining n ORFs into a single pool, 
tasks that need to be conducted for 
each individual clone (transformation, 
plating, colony picking, culture, 
induction, lysis, assays of solubility, 
and purification) are reduced n-fold. 
Where the previous method was 
lacking was in the need to quantitate 
the expression levels of the individual 
ORFs through the visualization of the 
proteins separated using 2D-PAGE. 
The throughput of this method was 
severely compromised by the need 
to conduct in-gel digestion and MS 
identification of all of the visualized 
spots. A significant portion of the 
spots were identified as host E. coli
proteins and therefore contribute no 
information concerning the expression 
efficiency of the proteins within the 
ORF pool. In the method presented in 
this article (Figure 1), proteins purified 
from a pool of 512 ORFs expressed 
in E. coli are tryptically digested and 
directly analyzed using LC-MS/MS. 
From these data, emPAI scores are 
calculated for each of the identified 
proteins to obtain a measure of their 
abundance. The pool of 512 ORFs 
was expressed and purified in three 
different experiments using the same 
conditions, and each of these mixtures 
was analyzed three times using the 
sample preparation and LC-MS/
MS method described in the Sample 
Preparation and MS/MS Analysis 
section.
The 15 most abundant proteins 
present within the mixture obtained 
from the expressed and purified ORFs 
based on the emPAI values deter-
mined in the triplicate analysis of the 
first ORF pool are shown in Table 1. 
As with our previous study that used 
2D-PAGE to quantitate the proteins 
prior to MS identification, SlyD, 
DnaK, GroEL, and OmpF were among 
the most abundant E. coli proteins. 
The emPAI values for the top 15 most 
abundant proteins are given for each 
of three separate LC/MS analysis. The 
reproducibility between analyses is 
very good, resulting in similar emPAI 
values for each experiment conducted 
for a single POET pool. Included 
in this table is the peptide count for 
each protein identified in the three 
separate LC/MS/MS experiments. 
Since the peptide count along with 
the theoretical peptide count is used 
to calculate the emPAI values, their 
reproducibility mirrors that of the 
corresponding emPAI values.
Three completely separate experi-
ments (i.e., expression, purification, 
sample preparation, and LC-MS/
MS analysis) were conducted 
using equivalent aliquots of the 
512 ORF-containing POET pool. 
Table 3. Rank of Proteins by emPAI Value from Three Separated Experiments
Protein emPAI Rank
Exp 1 Exp 2 Exp 3
FKBP-type peptidyl-prolyl cis-trans isomerase slyD 1 1 2
Chaperone protein DnaK 2 3 5
Protein CGI-38 3 7 4
UPF0235 protein C15orf40 4 2 1
60 kDa Chaperonin (GroEL) 5 6 6
Ferric uptake regulation protein 6 5 16
Programmed cell death protein 5 7 4 3
Ribosomal small subunit pseudouridine synthase A 8 9 8
Developmental pluripotency associated 4 9 10 7
26S Proteasome subunit p27 10 12 11
Catabolite gene activator 11 8 13
Major outer membrane lipoprotein precursor (OmpF) 12 18 9
Hypothetical protein MGC43122 13 15 19
HCV NS5A-transactivated protein 9 14 14 26
KIAA1536 protein 15 13 10
Optineurin 16 22 15
Hypothetical protein MGC4504 17 17 12
Coiled-coil domain-containing protein 16 18 16 17
RNA-binding protein with multiple splicing 19 29 40
Drebrin-like protein 20 11 14
30S Ribosomal subunit protein S15 21 32 28
Bifunctional polymyxin resistance arnA protein 22 23 27
Hypothetical protein MGC20255 23 19 35
KIAA1143 24 20 41
Sperm surface protein Sp17 25 69 111
emPAI, exponentially modi ed protein abundance index.
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The mean emPAI values and their 
associated standard deviations for the 
25 most abundant proteins found in 
the first POET experiment are listed 
in Table 2. The reproducibility over 
the three separate experiments is high, 
and the standard deviations for the 
mean emPAI values are low. While 
some minor variances are observed 
between the mean emPAI values for 
individual proteins in the three experi-
ments, this discrepancy is well within 
the limits of the random selection of 
peptide for sequencing that is seen in 
data-dependent MS/MS analysis of 
complex protein mixtures.
Each of the 25 proteins shown in 
Table 2 was ranked based on their 
emPAI values calculated from the 
three separate POET experiments that 
examined the same pool of 512 human 
ORFs. As shown in Table 3, proteins 
that ranked high in one experiment 
also typically ranked high in the other 
two experiments. For example, SlyD 
ranked as either the first or second 
most abundant protein based on emPAI 
values in the three POET experiments. 
Most of the proteins identified within 
the 10 most abundant proteins in the 
first experiment were also found 
within the top 10 of the other two 
experiments. These results highlight 
the reproducibility in conducting such 
studies to find the human clones that 
express high levels of proteins using 
this pooled method. One exception 
was Sp17, which gave a relatively high 
emPAI score in the first experiment, 
but ranked 69 and 11 in experiments 
two and three, respectively.
The ORFs corresponding to the 
top 11 emPAI scores were individ-
ually subcloned to serve as positive 
standards for individual expression. 
In addition, 11 clones that were not 
identified by LC-MS/MS among the 
pools of soluble expressed proteins 
were subcloned to serve as negative 
controls. Subclones were generated in 
pDest527, and each of the 22 clones 
was individually expressed under 
the same conditions as the POET 
experiment. Whole-cell extracts 
were prepared to identify expressed 
proteins, and soluble fractions were 
separated by mild detergent lysis. 
Samples of these fractions were run 
on SDS-PAGE gels, and the results 
are shown in Figure 2. All 11 positive 
clones (as identified by their emPAI 
values) showed strong expression in 
the whole-cell extracts, as shown in 
Table 4. Of these, six showed high 
levels of expression of soluble protein, 
while three additional proteins showed 
moderate levels of expressed soluble 
protein. Of the remaining two, soluble 
protein could be detected for one of 
the proteins using Western blotting 
analysis with an anti-His6 antibody, 
and appreciable levels of soluble 
protein could not be detected for the 
other.
In the individual validation of 
11 negative clones (Table 5), seven 
showed expression, although as a 
whole, levels were lower than those 
observed for the positive clones. Four 
negative clones showed no detectable 
expression in Coomassie-stained gels. 
Only one of the negative proteins was 
observed in the soluble fraction by 
Coomassie staining, with a low level 
of a second protein being detectable 
using Western blot analysis. The 
remaining nine negative clones 
showed no detectable soluble protein. 
Taken together, these data argue for 
the strong correlation of high emPAI 
scores from the soluble POET pool 
and solubility behavior in individual 
expression experiments. These data 
are also similar to the results obtained 
in our previous study, suggesting 
that the much more efficient and 
high-throughput direct LC-MS/
MS approach using emPAI scores is 
comparable in data quality to the more 
laborious 2D-PAGE gel approach to 
POET.
DISCUSSION
The current trend in biological 
sciences is to develop methods that 
collect large amounts of data in a 
high-throughput manner. These trends 
can be seen in genome sequencing, 
messenger RNA (mRNA) array 
analysis, and proteome character-
ization by MS. Unfortunately, the 
optimization of protein expression 
conditions has generally been limited 
to trial and error studies in which 
single clones are tested per exper-
iment (9–11). While automation has 
enabled multiplexing of these trial 
Table 4. Individual Expression Characteristics of 11 Human Clones That Showed High Expression Levels Based on emPAI Values 
Obtained in POET Experiment 
  ORF   ORF ID   emPAI   Expressed?   Soluble?   Figure 2 Gel Lane
Protein CGI-38 BC000691 0.456 Yes Good 1
UPF0235 protein C15orf40 BC019820 0.537 Yes Good 2
Programmed cell death protein 5 BC015519 0.436 Yes Good 3
Development pluripotency-4 BC032846 0.267 Yes Good 4
26S Proteasome subunit p27 BC002383 0.230 Yes Good 5
HCV NS5A-transactivated protein-9 BC007101 0.173 Yes Fair 6
KIAA1536 protein BC003177 0.221 Yes Fair 7
Optineurin BC013876 0.166 Yes Western 8
Hypothetical protein MGC4504 BC019625 0.176 Yes No 9
Coiled-coil domain containing 16 BC011584 0.168 Yes Fair 10
Debrin-like protein BC011667 0.199 Yes Good 11
The  nal column indicates the lane in the gel shown in Figure 2. ORF, open reading frame; POET, pooled ORF expression technology; emPAI, exponentially modi-
 ed protein abundance index.
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and error methods, the liquid handling 
apparatus required to conduct such 
endeavors is outside of the budget of 
most laboratories. POET is designed 
to provide a high-throughput method 
to simultaneously screen hundreds 
of ORFs to determine which clones 
express reasonable amounts of recom-
binant proteins under a specific set of 
cloning, expression, and purification 
conditions. POET is not designed 
to provide a complete quantitative 
assessment of every clone in a given 
pool, as there will undoubtedly be 
some ORFs that do not express any 
detectable level of protein. We have 
previously demonstrated the utility 
of combining hundreds of ORFs 
into a single expression system. 
Identification of clones that produced 
high levels of recombinant protein 
was hampered, however, by the need 
to quantitate by staining 2D-PAGE 
separated proteins (16). This need 
directly leads to the major rate-limiting 
step; coring out each individual protein 
spot, subjecting it to in-gel digestion, 
followed by identification using 
LC-MS/MS. In addition, considerable 
MS sample preparation and analysis 
time is wasted on the identification 
of E. coli host proteins, since these 
proteins are not distinguishable prior 
to MS analysis. The new, improved 
method presented in this paper uses 
a single LC-MS/MS analysis of the 
entire purified POET pool. Relative 
abundance is calculated directly by 
comparing the number of experimen-
tally identified peptides to the number 
of theoretically observable peptides for 
each individual protein. This method 
essentially reduces the time required 
to identify highly expressing human 
clones by 1/n (where n is the number 
of visualized protein spots) compared 
with the previous method that required 
visualization of 2D-PAGE separated 
proteins. Unfortunately, using a 
single dimension of separation prior 
to MS analysis limits the number of 
peptides that can be detected within 
a given pool. Using multidimensional 
chromatography, however, not only 
increases the analysis time but renders 
the results incompatible with emPAI 
calculations.
Overall, there is good correlation 
between an ORFs emPAI value calcu-
lated from the LC-MS/MS data and 
its ability to be expressed in a soluble 
form. Only one of the 11 clones, 
hypothetical protein MGC4504, which 
was predicted to provide a high level 
of soluble protein based on its emPAI 
value, failed to do so in the validation 
study of individual clones. While the 
reason for this discrepancy is not clear, 
it should be recognized that pools of E. 
coli cells each containing a different 
ORF grow in competition with each 
other. Any slowing of growth caused 
by expression of an ORF will result 
in underrepresentation of the corre-
sponding protein in the purified pool. 
A comparison of the entire list of 
emPAI values (see Supplementary 
Table S1 available online at www.
BioTechniques.com) shows that the 
ratio of human to E. coli proteins is 
approximately 3-fold higher in the 
bottom 50 percentile of all proteins 
that generated an emPAI value (c.f., 
6.4 to 2.3). The reason for, or the 
statistical relevance of, this difference 
is not obvious. It may be related to the 
fact that the 512 cloned human ORFs 
are under the control of an inducible 
vector, whereas the E. coli proteins 
are internally regulated based on the 
needed response by the organism. 
While E. coli may require a large 
number of proteins to be expressed for 
survival under the growth conditions 
used in this study, low levels of most 
of these proteins may be sufficient.
One drawback to the POET 
approach is that multiple proteins are 
likely being expressed in the same E. 
coli cell, meaning that a protein could 
potentially be stabilized by an inter-
action with another ORF. Conditions 
of higher stress in the POET pool 
could also lead to upregulation of 
chaperones, which might also assist 
in the soluble production of some 
proteins. The single negative clone 
that when individually expressed 
made considerable soluble protein, 
may be due to a pooling error, as the 
original POET pools were manually 
assembled.
The ability to screen a large 
number of cloned ORFs in a single 
high-throughput experiment opens up 
a number of opportunities in structural 
proteomics. For instance, interesting 
proteins, such as those classified as 
hypothetical that have no apparent 
homology to known proteins, can be 
prepared in a single pool and their 
expression efficiency quickly deter-
mined. Functionally related pools (e.g., 
kinases, phosphatase, transcription 
factors) can also be created, and their 
recombinant expression tested. POET 
can also be used in combination with 
Gateway technology as a filtering 
tool to determine the best expression 
vector for individual ORFs. For 
example, a pool of 500 ORFs could 
be cloned into multiple different 
vectors and expressed, purified, and 
analyzed directly by LC-MS/MS. 
The emPAI values calculated from 
each experiment would then indicate 
the optimal vector for each ORF. 
The same principle could be used to 
optimize the expression conditions 
(e.g., temperature, induction time) for 
pools of cloned ORFs.
While the quantitation of the 
protein’s relative abundance using 
a direct LC-MS/MS and emPAI 
approach represents a major 
improvement over the previous POET 
method that required 2D-PAGE/
staining, there are still other areas that 
can be improved upon. For example, 
this study analyzed a pool of 512 
cloned ORFs, while our previous study 
analyzed a pool containing 688. The 
effect that each recombinant protein 
may have on the expression of another 
cannot be easily determined in our 
study. Therefore, optimization of the 
number of cloned ORFs that can be 
most effectively analyzed in a single 
pool using POET needs to be deter-
mined. While conventional thinking is 
to make the pools as large as possible 
to increase the number of positive 
expressors found per experiment, 
large pools may have an adverse 
effect on the host machinery, thereby 
hampering efficiency. Analysis of 
smaller pools of ORFs may ultimately 
be a more efficient method, as it may 
minimize the effect of recombinant 
protein perturbation on the host cell.
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